https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-26 / Semin. Cancer Biol. 2016 06;37-38:96-105
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-26 / Semin. Cancer Biol. 2016 06;37-38:96-1052016-03-26 00:00:002019-02-15 09:18:09Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-24 / Thorac Cancer 2016 Jul;7(4):422-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-24 / Thorac Cancer 2016 Jul;7(4):422-72016-03-24 00:00:002019-02-15 09:18:22Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-202016-03-04 00:00:002016-03-04 00:00:00Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-01 / Oman Med J 2016 Mar;31(2):89-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-01 / Oman Med J 2016 Mar;31(2):89-972016-03-01 00:00:002019-02-15 09:18:11Hyperthermia: How Can It Be Used?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-22 / J. Exp. Clin. Cancer Res. 2016 Jan;35:18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-22 / J. Exp. Clin. Cancer Res. 2016 Jan;35:182016-01-22 00:00:002019-02-15 08:48:30Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-14 / Front Immunol 2015;6:663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-14 / Front Immunol 2015;6:6632016-01-14 00:00:002021-11-15 13:26:00Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-11 / Int J Hyperthermia 2016;32(2):187-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-11 / Int J Hyperthermia 2016;32(2):187-922016-01-11 00:00:002019-02-15 08:39:26Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-87
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-872015-12-21 00:00:002015-12-21 00:00:00Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-82015-11-02 00:00:002015-11-02 00:00:00Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-01 / Apoptosis 2015 Nov;20(11):1411-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-01 / Apoptosis 2015 Nov;20(11):1411-92015-11-01 00:00:002019-02-15 09:18:03Hyperthermia: an effective strategy to induce apoptosis in cancer cells
